GYRE
Gyre Therapeutics Inc.
7.30$
+0.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.64 | 5.93 | 0.51 | 0.30 | 0.00 | – | 1.09 | 0.24 | 1.35 | 1.72 | 1.03 | 1.13 | |
| 16.37 | 20.18 | 13.55 | 0.05 | 0.01 | 0.01 | 0.48 | 0.25 | 0.06 | 0.07 | 0.04 | 0.05 | |
| -10.74 | -14.25 | -13.04 | 0.25 | -0.01 | -0.01 | 0.61 | -0.01 | 1.29 | 1.65 | 1.00 | 1.08 | |
| 16.37 | 20.18 | 14.84 | 3.75 | 1.91 | 3.65 | 2.76 | 2.11 | 0.22 | 0.21 | 0.12 | 0.13 | |
| 12.60 | 32.49 | 11.89 | 2.92 | 1.10 | 1.12 | 0.84 | 0.61 | 0.23 | 0.22 | 0.16 | 0.20 | |
| 26.86 | 52.67 | 26.73 | 6.62 | 3.02 | 4.76 | 3.61 | 2.72 | 1.17 | 2.67 | 0.84 | 0.97 | |
| -23.34 | -46.74 | -26.22 | -6.37 | -3.02 | -4.77 | -2.99 | -2.73 | 0.12 | -1.02 | 0.16 | 0.11 | |
| 0.07 | 5.01 | – | – | – | – | – | 0.01 | 0.01 | – | – | – | |
| -20.56 | -49.99 | -21.76 | -6.30 | -2.68 | -4.60 | -2.93 | -2.87 | 0.12 | -1.17 | 0.23 | 0.14 | |
| 10.83 | 1.75 | 3.96 | -0.05 | 0.34 | -0.19 | -0.04 | 0.00 | 0.07 | 0.13 | 0.05 | 0.04 | |
| -101.40 | -49.99 | -21.76 | -6.30 | -2.68 | -4.60 | -2.90 | -2.87 | 0.03 | -1.41 | 0.12 | 0.05 | |
| -21.23 | -43.40 | -25.72 | -6.32 | -3.02 | -4.58 | -2.93 | -2.86 | 0.14 | 0.31 | 0.17 | 0.16 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.